Mice protected by the unconventional vaccine survived exposure to lethal doses of seven of nine widely divergent influenza viruses, according to researchers from the University of Nebraska-Lincoln in the US.
Those that received higher doses of the vaccine did not even get sick. In contrast, mice that received traditional flu shots or nasal sprays all sickened and died when exposed to the same viruses.
Also Read
While it is too soon to say the approach could be successfully used in humans, it appears to be a promising avenue towards a universal flu shot, said Eric Weaver, an assistant professor at the University of Nebraska-Lincoln.
The study is the first to report on whether a universal flu shot could be created by using a combination of multiple genes shared at the ancestral level by flu strains circulating today, he said.
"The ultimate goal is to be able to vaccinate once and provide lifelong protection," said Weaver, who led the study published in the journal Scientific Reports.
The conventional influenza vaccine platform uses weakened or dead versions of the influenza virus to stimulate immunity against hemagglutinin (HA), a spike-shaped protein that extends from the surface of the virus and attacks cells.
Conventional vaccines have been shown to be less than 60 per cent effective when they are successfully matched to the currently circulating strain. They are far less effective when mismatched, researchers said.
"An ideal influenza vaccine would be inexpensive, provide long-lasting immunity, require few immunisations and would work against all variants of the virus," Weaver said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
